BAUSCH + LOMB CORPORATION COMMON SHARES (BLCO)
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
📈 **POSITIVE** • High confidence analysis (88%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business